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a  b  s  t  r  a  c  t
The  manipulation  of the  RNA  interference  pathway  using  small  interfering  RNA  (siRNA)
has  become  the  most  frequently  used  gene  silencing  method.  However,  siRNA  delivery
into  primary  cells,  especially  primary  macrophages,  is  often  considered  challenging.  Here
we  report  the  investigation  of  the  suitability  of  two  methodologies:  transient  transfection
and  electroporation,  to deliver  siRNA  targeted  against  the  putative  immunomodulatory
gene  Mediterranean  fever  (MEFV)  into  primary  bovine  monocyte-derived  macrophages
(bMDM).  Eleven  commercial  transfection  reagents  were  investigated  with  variable  results
with respect  to siRNA  uptake,  target  gene  knock-down,  cell toxicity  and  type I interferon
(IFN)  response  induction.  Three  transfection  reagents:  Lipofectamine  2000,  Lipofectamine
RNAiMAX  and  DharmaFECT  3, were  found  to consistently  give  the  best  results.  However,
all  the  transfection  reagents  tested  induced  an  IFN  response  in the  absence  of  siRNA,
which  could  be minimized  by  reducing  the transfection  reagent  incubation  period.  In addi-
tion,  optimized  siRNA  delivery  into  bMDM  by  electroporation  achieved  comparable  levels
of target  gene  knock-down  as transient  transfection,  without  a  detectable  IFN  response,
but  with  higher  levels  of  cell  toxicity.  The  optimized  transient  transfection  and electro-
poration  methodologies  may  provide  a starting  point  for optimizing  siRNA  delivery  into
macrophages  derived  from  other  species  or other  cells  considered  difﬁcult  to  investigate
with  siRNA.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
BY license  (http://creativecommons.org/licenses/by/3.0/).. Introduction
The discovery of the RNA inference (RNAi)
athway, where double-stranded RNA (dsRNA) post-
ranscriptionally silences gene expression (Fire et al.,Please cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
998) and the subsequent demonstration that this
athway could be utilized with short, exogenous RNA
equences (Elbashir et al., 2001) have revolutionized
∗ Corresponding author. Tel.: +44 131 6519100; fax: +44 131 6519105.
E-mail address: Kirsty.Jensen@roslin.ed.ac.uk (K. Jensen).
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
165-2427/© 2014 The Authors. Published by Elsevier B.V. Thi
http://creativecommons.org/licenses/by/3.0/).many areas of cellular research. The RNAi pathway is
evolutionary conserved, being present in plants, fungi and
animal cells, and has multiple functions; protecting cells
from viral dsRNA and transposons, as well as regulating
gene expression by the degradation of mRNA, translational
repression and chromatin modiﬁcations (reviewed by
Dykxhoorn and Lieberman, 2005). In the cell cytoplasm,
endogenous microRNA (miRNA) or exogenous dsRNA arearison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
typically processed into 21–23 nucleotide short interfering
RNA (siRNA) by the Dicer protein and integrated into the
multi-subunit RNA-induced silencing complex (RISC). The
RNA strands are separated and the antisense (guide) strand
s is an open access article under the CC BY license
 ING Model
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binds mRNA with complementary sequence, resulting in
mRNA cleavage or translational repression, depending on
the extent of sequence complementarity (reviewed by
Shan, 2010).
The ability to harness the RNAi pathway, either by the
uptake of synthetic siRNA into cells, or by the introduc-
tion of vectors that express short hairpin RNA (shRNA)
that mimic  miRNA precursors, allows the silencing of vir-
tually any gene of any organism and has proved to be an
elegant tool for the reverse genetic investigation of gene
function. siRNA libraries are now available for humans
and mice, which allow high throughput screening of
thousands of genes simultaneously, which have expanded
our knowledge and identiﬁed novel genes involved in cel-
lular pathways and host–pathogen interactions (Zhou et al.,
2008; Jayaswal et al., 2010). Since nearly any gene can
be silenced the technology has great therapeutic poten-
tial, if the siRNAs can be delivered to the desired cells
or organs, and several siRNA therapeutics are currently
in phase II and III trials (reviewed by Whitehead et al.,
2009). A major advantage of employing the RNAi path-
way is that genes can be silenced in non-model species,
where reagents are limited but sequence information is
available. This is particularly true for farm animals, where
genome sequencing efforts have resulted in large sequence
resources, but there are limited reagents, e.g. antibodies,
available and few transgenic animals. Gene silencing by
siRNA are now routinely used in studies on cattle (Ma  and
Corl, 2012), sheep (Smith et al., 2012), chickens (Qi et al.,
2013), pigs (Shi et al., 2013) and salmon (Kumari et al.,
2013) using cell lines and some primary cells. However,
there are difﬁculties introducing exogenous nucleotides,
including siRNA, into certain primary cells, especially pri-
mary macrophages (reviewed by Zhang et al., 2009) and
studies using siRNA to investigate macrophage genes lag
behind those for other cell types. There are several rea-
sons for this difﬁculty, which relate to the function of
macrophages. Macrophages play several important roles
in the immune system. They detect pathogens and dan-
ger signals and respond by phagocytosis and destruction
of pathogens, antigen presentation and the secretion of
immunological mediators. For this they express many
enzymes that can degrade nucleotides and are primed
to react rapidly and vigorously to the presence of for-
eign particles. Our research focuses on investigating the
role of bovine macrophages during infection with various
pathogens, e.g. Theileria annulata (Jensen et al., 2009). As
part of an on-going project we wished to investigate the
functional importance of macrophage expressed genes by
targeted silencing of genes in primary bovine monocyte-
derived macrophages (bMDM). To our knowledge the use
of siRNA or shRNA to knock-down gene expression in pri-
mary bovine macrophages has not been reported before.
Therefore we set about investigating methods to silence
bovine macrophage genes utilizing the RNAi pathway. Viral
vectors, e.g. lentiviruses, can integrate into the genomes of
non-dividing cells, resulting in constitutive expression ofPlease cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
shRNA and long-term gene silencing (reviewed by Zhang
et al., 2009) and lentiviruses have successfully transduced
shRNA into primary human macrophages (Lee et al., 2003).
However, one of the functions of macrophages is to respond PRESS
munopathology xxx (2014) xxx–xxx
to the presence of viruses, which may  affect a subse-
quent response to challenge with the pathogen being
investigated. Therefore, our efforts have concentrated on
optimizing transient gene silencing in bMDM using the less
immunogenic siRNA.
There are two  predominant techniques that have
been successfully used to introduce siRNA into primary
macrophages derived from other, non-bovine species;
transient transfection (Zhang et al., 2005; Wati et al., 2007;
Behmoaras et al., 2008; Lietzen et al., 2011) and electropo-
ration (Wiese et al., 2010). Transient transfection involves
the use of cationic lipids which interact with negatively
charged RNA or DNA and form lipoplexes by electrostatic
forces (reviewed by Zuhorn et al., 2007) which are taken up
by endocytosis. Electroporation involves the application of
an external electric ﬁeld which temporarily increases cell
plasma permeability, causing pores to form in the plasma
membrane through which RNA or DNA can directly enter
cells (Neumann et al., 1982). Here we  report our investiga-
tion of siRNA gene silencing in bovine bMDM and describe
the optimization of siRNA delivery by transient transfection
and electroporation.
2. Materials and methods
2.1. Preparation of bovine monocyte-derived
macrophages (bMDM)
Peripheral blood from three female Holstein-Friesian
cattle, maintained at The Roslin Institute, was collected
aseptically into blood bags containing the anticoagulant
CPDA-1 (Sarstedt). All animals were clinically normal and
all experimental protocols were authorized under the
UK Animals (scientiﬁc procedures) Act, 1986. In addi-
tion, The Roslin Institute’s Animal Welfare and Ethics
Committee (AWEC) ensure compliance with all relevant
legislation and promote the adoption and developments
of the 3Rs (reduction, replacement, reﬁnement). Periph-
eral blood mononuclear cells (PBMC) were separated
by density gradient centrifugation as described previ-
ously (Jensen et al., 2006). The PBMC were resuspended
in RPMI-1640 medium without serum (Invitrogen) at
5 × 106 cells/ml and initially cultured for 2 h at 37 ◦C, after
which time the medium and non-adhered cells were
replaced with RPMI-1640 supplemented with 20% foetal
bovine serum (FBS), 4 mM l-glutamine and 50 M -
mercaptoethanol. The adhered cells were cultured for
7 days at 37 ◦C, with a change of medium on day 4.
During this time the monocytes within the PBMC were
observed to develop macrophage morphology and the
up-regulation of the macrophage markers; CD64, CD68, v-
maf  musculoaponeurotic ﬁbrosarcoma oncogene homolog
(avian) (MAF), macrophage scavenger receptor 1 (MSR1),
scavenger receptor class B, member 2 (SCARB2) and trigg-
ering receptor expressed on myeloid cells 2 (TREM2), was
detected by RT-PCR (see Supplementary File).
After 7 days the adhered cells were vigorously washedarison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
three times with PBS to remove the remaining non-adhered
cells. The adherent cells were removed from the plates
by incubation with TrypLE Express (Invitrogen) and then
resuspended in RPMI-1640 supplemented with 20% FBS.
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he purity of the macrophage population was assessed
y ﬂow cytometry, using a mouse anti-bovine SIRPA
CD172) antibody directly conjugated with RPE-Cy5 (AbD
erotec: Cat. No. MCA2041C), which conﬁrmed that the
acrophage purity exceeded 90% (see Supplementary File).
ll ﬂow cytometry analysis was carried out on a CyAn
ow cytometer (Beckman Coulter) using the Summit soft-
are.
.2. siRNA duplexes
The AllStars negative control siRNA, which has no
omology to any known mammalian gene, labelled with
uorescein isothiocyanate (FITC) (Qiagen) was  used to
ssess the efﬁciency of siRNA uptake and as the neg-
tive control siRNA in the knock-down experiments.
s part of on-going studies, siRNA were designed for
he inﬂammasome-associated bovine Mediterranean fever
MEFV), using the RefSeq sequence XM 002706315. The
iRNA were designed by Sigma–Aldrich and three siRNA
ere purchased and tested. All three siRNA induced
arget gene knock-down and the results for MEFV#3 (5′-
TTGCTTAATAAATCCTTA-3′) are described here. Stocks
20 M)  were prepared of each siRNA, which were aliquot-
ed and stored at −20 ◦C.
.3. Transfection
The efﬁcacy of eleven transfection reagents to promote
ptake of the FITC-labelled siRNA was investigated. The
MDM were seeded at 1 × 105 cells/well in 24 well plates.
fter 3 h incubation at 37 ◦C, during which time the bMDM
ad adhered to the plastic, the cells were transfected
ith 50 nM siRNA. The transfection reagents; HiPerFect
Qiagen), INTERFERin (Polyplus), Lipofectamine RNAiMAX
Invitrogen), Lipofectamine 2000 (Invitrogen), Dharma-
ECT 1, DharmaFECT 2, DharmaFECT 3 and DharmaFECT
 (Dharmacon), siPORT Amine (Ambion), X-tremeGENE
Roche) and N-TER (Sigma–Aldrich) were used according
o the manufacturers’ instructions. After 16 h incubation
t 37 ◦C the bMDM were harvested and analyzed by ﬂow
ytometry.
To investigate the efﬁcacy of each siRNA to knock-
own expression of the target genes, the bMDM were
eeded at 2 × 105 cells/well in 24 well plates and, after
4 h incubation at 37 ◦C, were transfected with transfec-
ion reagent alone or with 50 nM siRNA. The transfection
eagents were used at the optimum conditions deter-
ined by the previous experiments. To investigate any
esponse of bMDM to the transfection reagents the bMDM
ere either incubated at 37 ◦C for 48 h or the medium
as changed after 24 h and the bMDM cultured for a fur-
her 24 h before being harvested and the RNA extracted.
o investigate MEFV knockdown, bMDM were incubated
t 37 ◦C for 24 h, then the medium was replaced and
MDM were cultured for an additional 24 h. To stimulatePlease cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
EFV expression bMDM were activated with 100 ng/ml
scherichia coli-derived lipopolysaccharide (LPS) (Sigma)
nd bMDM were harvested and RNA extracted 2 h post
ctivation. PRESS
munopathology xxx (2014) xxx–xxx 3
2.4. Electroporation
The ability of electroporation to deliver FITC-labelled
AllStar negative control siRNA (Qiagen) into bMDM was  ini-
tially investigated and the protocol optimized. Two  buffers
were tested; Opti-MEM I (Invitrogen) and siPORT siRNA
electroporation buffer (Ambion). The siRNA was  trans-
ferred into 1 mm electrode gap cuvettes and either buffer
was added to give a total volume of 50 l. The bMDM sus-
pension in either buffer, at 4 × 107 cells/ml, was added to
the cuvette and mixed by pipetting to give a ﬁnal vol-
ume of 100 l, containing 2 × 105 cells and 1 M siRNA. The
cuvette was  immediately pulsed at a range of voltage and
capacitance levels using a Gene Pulser electroporator (Bio-
Rad). The electroporated bMDM were incubated at 37 ◦C for
10 minutes before being transferred into 24 well plates and
the volume increased to 0.5 ml/well. After 16 h incubation
at 37 ◦C the bMDM were harvested and analyzed by ﬂow
cytometry.
The electroporation of target gene siRNA was carried
out using a scaled up version of the optimized conditions.
bMDM were resuspended at 1.2 × 107 cells/ml in Opti-
MEM  I and electroporated with 3 M siRNA at 300 V and
25 F. After 10 min  incubation at 37 ◦C the bMDM were
transferred into 6 well plates and the volume increased to
4 ml/well. Unless stated otherwise, the bMDM were incu-
bated at 37 ◦C for 48 h before being harvested and the RNA
was extracted.
2.5. Quantiﬁcation of siRNA uptake and cytotoxicity
After 16 h incubation at 37 ◦C the bMDM transfected
or electroporated with FITC-labelled siRNA were har-
vested using TrypLE Express, washed with RPMI-1640
supplemented with 20% FBS and resuspended in 1 ml PBS
supplemented with 0.5% FBS. Cell toxicity was measured
by staining the cells with 1 M SYTOX Blue dead cell stain
(Invitrogen) according to the manufacturer’s protocol. The
bMDM were analyzed using a CyAn ﬂow cytometer (Beck-
man  Coulter), the bMDM population was  gated, by size
and complexity (see Supplementary File), and the percent-
age of FITC labelled and SYTOX Blue labelled bMDM was
measured.
2.6. Quantitative (q)RT-PCR analysis of target gene
knock-down and interferon response
Total RNA was  extracted from the bMDM samples using
the RNeasy Mini Kit (Qiagen) according to the manu-
facturer’s instructions with on-column DNase digestion.
The quality and quantity of the resulting RNA was deter-
mined by gel electrophoresis and NanoDrop ND-1000
spectrophotometer (Thermo Scientiﬁc). First strand cDNA
was reverse transcribed from 0.1 to 0.5 g total RNA using
oligo(dT) primer and Superscript II (Invitrogen) according
to the manufacturer’s instructions. The resulting cDNA was
diluted 1:25 for all genes. The mRNA levels of MEFV andarison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
selected type I interferon (IFN)-response genes were quan-
tiﬁed by qPCR using the FastStart Universal SYBR Green
mastermix (Roche) as described previously (Jensen et al.,
2009). Oligonucleotides were designed for the target gene
 ING Model
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MEFV and the IFN-response gene interferon-induced pro-
tein with tetratricopeptide repeats 1 (IFIT1) using Primer3
(Rozen and Skaletsky, 2000) and Netprimer (Biosoft
International) software. The sequences of the MEFV
oligonucleotides are 5′-GGACCCCTCAATCCAGAAAT-3′ and
5′-GATGCTCCCCAATCATCATC-3′. The sequences of the
IFIT1 oligonucleotides are 5′-GCTGCCAAGTTTTACCGAAG-
3′ and 5′-CAAAGCCCTGTCTGGTGATG-3′. The relative quan-
tities of mRNA were calculated using the method described
by Pfafﬂ (2001), using the qRT-PCR results for chromo-
some alignment maintaining phosphoprotein 1 (CHAMP1),
previously known as Chromosome 13 open reading frame
8, to calculate differences in the template RNA levels and
thereby standardize the results for the genes of interest
(Jensen et al., 2009).
3. Results and discussion
3.1. Delivery of siRNA by transfection reagents
Liposome based transfection reagents provide a simple
and cost-effective method to introduce siRNA into cells and
is therefore the method of choice for many researchers.
Successful silencing of target genes in non-bovine primary
macrophages with siRNA delivered by transient transfec-
tion has been reported previously (Zhang et al., 2005; Wati
et al., 2007; Behmoaras et al., 2008; Lietzen et al., 2011).
3.1.1. Screening of transfection reagents
We initially tested the suitability of eleven commer-
cially available transfection reagents to promote siRNA
uptake by bMDM.  The preliminary experiments inves-
tigated the efﬁcacy of three concentrations of each
transfection reagent, within the range suggested by the
manufacturers, to promote the uptake of a FITC-labelled
non-target control (NTC) siRNA and the levels of cell
toxicity that were induced. The efﬁcacy of the eleven
transfection reagents varied considerably, with the max-
imum percentage of bMDM taking up siRNA ranging
between 19% and 86% cells with the different transfec-
tion reagents (Fig. 1). The reagents siPORT Amine, N-TER
and DharmaFECT 1 failed to promote uptake of signiﬁcant
amounts of siRNA at the three different concentrations.
The use of DharmaFECT 2 and DharmaFECT 4 resulted
in siRNA up-take by a high proportion of bMDM,  but
caused considerable cell toxicity. The remaining transfec-
tion reagents: HiPerFect, INTERFERin, Lipofectamine 2000,
Lipofectamine RNAiMAX, X-tremeGENE and DharmaFECT
3 promoted good up-take of siRNA by bMDM,  without
causing signiﬁcant cell death. The levels of siRNA up-take
were observed to increase with increasing levels of the
transfection reagents, except for X-tremeGENE and N-TER.
However, this enhanced up-take was usually associated
with increased cell toxicity.
3.1.2. Investigation of potential off-target effects of
transfection reagentsPlease cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
The results described above illustrate that siRNA are
readily taken up by bMDM using certain transfection
reagents. However, the suitability of transfection reagents
also depends on the absence of the induction of off-target PRESS
munopathology xxx (2014) xxx–xxx
effects. The potential off-target effects induced by ﬁve
transfection reagents: INTERFERin, Lipofectamine 2000,
Lipofectamine RNAiMAX, X-tremeGENE and DharmaFECT
3, were investigated. These transfection reagents were
selected for further study on the basis of their combined
performance in terms of siRNA uptake and the cell toxicity
induced (Fig. 1). bMDM were cultured with each trans-
fection reagent, at the optimal concentration for siRNA
uptake, for 48 h without siRNA. This time-point was cho-
sen because several investigated siRNA induced maximal
gene-silencing at this time in previous optimization exper-
iments (data not shown). The expression of known type I
IFN-response genes was then measured at the mRNA level
by qRT-PCR. All ﬁve transfection reagents induced the up-
regulation of IFIT1, ranging from 25-fold for Lipofectamine
2000 to 395-fold up-regulation with X-tremeGENE (Fig. 2A
– 48 h incubation). Similar results were also measured
for other type I IFN-response genes; interferon induced
transmembrane protein 1 (IFITM1), myxovirus (inﬂuenza-
virus) resistance 1, interferon-inducible protein (MX1) and
2′,5′-oligoadenylate synthetase 1 (OAS1) (data not shown).
Off target transcriptional effects caused by the transfec-
tion reagents alone have been reported previously (Yoo
et al., 2006; Tagami et al., 2008; Lacaze et al., 2009). In
the absence of siRNA, Lipofectamine 2000 induced dif-
ferential expression of over 500 genes in murine bone
marrow derived macrophages, including many classic type
I IFN response genes (Lacaze et al., 2009). Interestingly, if
the medium was changed 24 h post treatment with the
transfection reagents and the bMDM were cultured for a
further 24 h, the IFN-response was not observed in bMDM
(Fig. 2A – 24 h incubation). The maximum fold increase
in IFIT1 mRNA that was measured was 6-fold induced
by Lipofectamine RNAiMAX. Therefore the transfection
reagents induce a response in bMDM,  but this appears
to be quickly dampened down by removing the stimulus.
However, using a similar protocol 92 genes were still differ-
entially expressed in human ﬁbrosarcoma cells (HT1080)
24 h after Lipofectamine 2000 was  removed from the cul-
tures (Tagami et al., 2008).
3.1.3. Target gene knock-down using transfection
reagents
siRNA uptake does not guarantee target gene knock-
down (Lundberg et al., 2007; Metwally et al., 2012) and
therefore the ability of the ﬁve transfection reagents
to promote target gene knock-down using siRNA was
investigated. bMDM were treated with optimal concen-
trations of transfection reagent and siRNA against the
inﬂammasome-associated molecule MEFV, the function
of which we are currently investigating. The bMDM were
cultured with transfection reagents and siRNA for 24 h
and then the medium was  replaced and the bMDM were
cultured for a further 24 h. Levels of MEFV mRNA are below
detectable levels in resting bMDM and therefore bMDM
were stimulated with LPS to induce MEFV expression and
levels of MEFV mRNA were measured by qRT-PCR 2 h postarison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
activation. The delivery of MEFV speciﬁc siRNA by the
transfection reagents INTERFERin, Lipofectamine 2000,
Lipofectamine RNAiMAX and DharmaFECT 3 reduced
the MEFV mRNA levels to between 13.0 and 34.0% of
ARTICLE IN PRESSG ModelVETIMM-9158; No. of Pages 9
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f  viable bMDM (black diamonds) were measured by ﬂow cytometry. The
nimals.
hat measured in activated non-siRNA treated cells (NC)
Fig. 2B). X-tremeGENE consistently failed to knock-down
RNA for MEFV (Fig. 2B) or other target genes (data
ot shown), illustrating that up-take of siRNA does not
quate with target gene knock-down. MEFV gene silencing
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r those of other investigated genes (data not shown).
he transfection reagents alone and the NTC siRNA did
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EFV levels were 130% higher in TC than NC, although
his was not statistically signiﬁcant (P = 0.08). However,
EFV mRNA levels in NTC samples were statistically
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n additional effect on MEFV mRNA expression.Please cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
Speciﬁc anti-bovine MEFV antibodies are not com-
ercially available and constructing one was beyond
he scope of this work. Unfortunately attempts to detect
ovine MEFV using three different anti-human MEFVtage of bMDM transfected with FITC-siRNA (grey bars) and the percentage
s representative of three repeat experiments using bMDM from different
polyclonal antibodies, which due to MEFV sequence con-
servation are predicted to cross-react with bovine MEFV,
failed. Therefore we have been unable to directly conﬁrm
knock-down of MEFV at the protein level. However, we
have shown that knocking-down bovine MEFV, which
regulates inﬂammasome activity (Seshadri et al., 2007),
affects IL1B protein release (Jensen et al., in prep). This
result is in agreement with studies knocking down human
MEFV using a similar experimental design (Seshadri et al.,
2007), providing indirect evidence that the MEFV siRNA is
reducing bovine MEFV at the protein level.
Amongst the eleven transfection reagents investigated,
Lipofectamine 2000, Lipofectamine RNAiMAX and Dhar-
maFECT 3 consistently gave the best results, in terms
of siRNA uptake and target gene knockdown with min-
imal cell toxicity and type I IFN response induction.
Therefore, all three transfection reagents appear suit-
able for use in bMDM.  Lipofectamine 2000 and RNAiMAX
have successfully been used for siRNA gene silencing
in murine bone-marrow derived macrophages (Lacaze
et al., 2009) and human monocyte-derived macrophages
(hMDM) (Wati et al., 2007) respectively. However, in
another study siRNA were delivered into hMDM using
DharmaFECT 1 (Behmoaras et al., 2008) which was  unsuit-arison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
able for use in bMDM,  resulting in low levels of siRNA
uptake. Furthermore, siPORT Amine was found to be the
best transfection reagent for siRNA delivery into porcine
alveolar macrophages (Zhang et al., 2005), which failed to
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Fig. 2. Transient transfection reagents induce a type I interferon (IFN)-response in bovine monocyte-derived macrophages (bMDM) in the absence of
siRNA.  The siRNA uptake efﬁcacy and off-target effects of ﬁve transfection reagents, INTERFERin (INT), Lipofectamine RNAiMAX (RNA), Lipofectamine 2000
(L2K), X-tremeGENE (XTG) and DharmaFECT 3 (DF3) were investigated. (A) bMDM were cultured with pre-determined concentrations of the transfection
reagents in the absence of siRNA for 48 h (48 h incubation) or the medium was  changed 24 h post transfection reagent treatment and cultured for a
further 24 h (24 h incubation). The mRNA levels of the type I IFN-response gene interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) were
measured by qRT-PCR. The results are expressed as the IFIT1 mRNA fold difference compared to that measured in untreated cells (NC). Error bars denote the
variation between three technical replicates. (B) bMDM were transfected with MEFV siRNA using the ﬁve transfection reagents for 24 h before the medium
was  replaced. MEFV mRNA levels in bMDM transfected with (NTC) and without (TC) non-target control siRNA using Lipofectamine RNAiMAX were also
2 h. The
nical reinvestigated. After 48 h the bMDM were activated with 100 ng/ml LPS for 
to  that measured in NC. Error bars denote the variation between three tech
bMDM  from different animals.
facilitate siRNA uptake by bMDM.  Therefore, there is con-
siderable variation in the efﬁcacy of transfection reagents
to deliver siRNA into macrophages derived in different
ways and from different species.
3.2. Delivery of siRNA by electroporation
The majority of cationic liposome-delivered siRNAs
enter cells by endocytosis (Lu et al., 2009). The resulting
off-target immune response of cells to siRNA and trans-
fection reagents has been associated with their presence
in the endosome (Sioud, 2005; Yoo et al., 2006). An alter-
native approach to introduce siRNA into cells is the use
of electroporation, the application of an external electrical
ﬁeld which temporarily increases cell plasma permeabil-
ity (Neumann et al., 1982), thus delivering siRNA directly
into the cell cytoplasm. Using this technique can prevent
the sequence-speciﬁc immune response induced by siRNA
(Sioud, 2005) and has successfully been used to intro-
duce siRNA into primary murine bone-marrow derived
macrophages, resulting in target gene knock-down (Wiese
et al., 2010). Therefore, the suitability of this approach to
deliver siRNA for targeted gene knock-down in bMDM was
investigated.Please cite this article in press as: Jensen, K., et al., Comp
bovine monocyte-derived macrophages by transfection and 
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
3.2.1. Optimization of siRNA uptake by electroporation
Initially cell viability and uptake of FITC-labelled NTC
siRNA were optimized. The cells were tested in two media, results are expressed as the percentage MEFV mRNA detected compared
plicates. The results are representative of three repeat experiments using
Opti-MEM I and siPORT siRNA electroporation buffer, and
the voltage and capacitance settings were adjusted. The
different conditions altered the uptake of siRNA and cell
viability considerably (Fig. 3). The siPORT siRNA electro-
poration buffer was not suitable for use with bMDM,  its
use resulted in over 80% cell death in all electropora-
tion conditions tested. In contrast, the use of Opti-MEM
I reduced the level of cell toxicity, although this varied
considerably depending on the electroporation conditions.
The highest level of siRNA uptake, exceeding 60%, was
observed at voltage 200 V and 250 V with capacitance set
at 125 F, although these maximal values were lower
than observed with the transfection reagents (Fig. 1).
However, these conditions induced relatively high lev-
els of cell toxicity, killing over 30% bMDM.  Taking into
account the siRNA uptake and cell toxicity induced, the
electroporation conditions 300 V and 25 F were optimal
(Fig. 3) and these settings were used in the later experi-
ments.
3.2.2. Investigation of target gene knock-down and
potential off-target effects with electroporation
The ability of electroporated siRNA to induce target gene
knock-down in bMDM was investigated. bMDM were elec-arison of small interfering RNA (siRNA) delivery into
electroporation. Vet. Immunol. Immunopathol. (2014),
troporated with MEFV siRNA, NTC siRNA or in the absence
of siRNA and MEFV mRNA levels were measured 2 h post
activation of bMDM incubated with siRNA for 48 h. MEFV
mRNA levels were reduced by 75% in bMDM electroporated
Please cite this article in press as: Jensen, K., et al., Comparison of small interfering RNA (siRNA) delivery into
bovine monocyte-derived macrophages by transfection and electroporation. Vet. Immunol. Immunopathol. (2014),
http://dx.doi.org/10.1016/j.vetimm.2014.02.002
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Fig. 3. Optimization of siRNA uptake by electroporation. The ability of bovine monocyte-derived macrophages (bMDM) in different buffers, Opti-MEM and
siPORT siRNA electroporation buffer, to take up 1 M FITC-labelled siRNA after electroporation at various voltage and capacitance settings was compared.
After  16 h the percentage of bMDM transfected with FITC-siRNA (grey bars) and the percentage of viable bMDM (black diamonds) were measured by ﬂow
cytometry. The result is representative of three repeat experiments using bMDM from different animals.
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Fig. 4. Electroporation is an effective method for siRNA uptake in bovine monocyte-derived macrophages (bMDM) without inducing a type I interferon
(IFN)  response. bMDM were electroporated without siRNA (EC), with MEFV siRNA or non-target control siRNA (NTC siRNA). (A) After 48 h the electroporated
bMDM were activated with 100 ng/ml LPS for 2 h. The results are expressed as the percentage MEFV mRNA detected compared to that measured in untreated
cells  (NC). Error bars denote the variation between three technical replicates. (B) After 48 h cells were harvested and mRNA levels of the IFN-response gene
interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) were measured by qRT-PCR. The results are expressed as the IFIT1 mRNA fold difference
compared to that measured in NC. Error bars denote the variation between three technical replicates. The results are representative of three repeat
experiments using bMDM from different animals.
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with MEFV siRNA (Fig. 4A). This is comparable to levels
measured in bMDM transfected with this siRNA (Fig. 2B).
Neither the electroporation process nor the presence of
the siRNA was associated with any change in IFIT1 levels
(Fig. 4B) or any other IFN-response gene investigated (data
not shown). Therefore electroporation is a suitable alter-
native to the use of transfection reagents to deliver siRNA
into bMDM.
3.3. Conclusions
The results reported here demonstrate that, contrary to
the dogma that primary macrophages are difﬁcult to trans-
fect, primary bMDM can be electroporated or transfected
with siRNA resulting in good levels of target gene silencing.
The methodologies described above have now been used
to successfully silence nine genes in bMDM (manuscripts
in preparation). It is hoped that these methodologies will
provide a starting point for optimizing siRNA use in pri-
mary macrophages from other species and other primary
cells which are regarded as being hard to transfect, e.g.
dendritic cells. Several of the tested transfection reagents
appear suitable for use: DharmaFECT 3, Lipofectamine
2000 and RNAiMAX. Electroporated siRNA silenced the
MEFV gene to a comparable level as transfected siRNA,
but the procedure resulted in more cell death and the
remaining cells were less robust than transfected cells
in down-stream activation studies (data not shown). The
transfection protocols allow siRNA uptake by adhered
cells and therefore it is much easier to reapply siRNA
to bMDM,  thereby extending the period of gene silenc-
ing, than by electroporation. The choice of transfecting or
electroporating siRNA into cells depends on the individ-
ual experiments. The fragility of electroporated cells to
challenge means that the use of transfection reagents is
more suitable than electroporation for our work investi-
gating the role of host macrophage genes in the response
to infection. However, the increased expression of MEFV
with transfection reagent treatment illustrates that both
methodologies do affect macrophages and highlights the
importance of the inclusion of suitable controls in siRNA
experiments.
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